Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection-Reference-Cited by-同舟云学术

Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection

Published:2021-10-31 Issue:2 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Taubner Benjamin¹,Peredo-Wende Ruben²,Ramani Ananthakrishnan³,Singh Gurpreet⁴,Strle Klemen⁵⁶,Cady Nathaniel C.¹^ORCID

Affiliation:

1. College of Nanoscale Science & Engineering, SUNY Polytechnic Institute, Albany, New York, USA

2. Division of Rheumatology, Albany Medical Center, Albany, New York, USA

3. Division of Infectious Diseases, Albany Medical Center, Albany, New York, USA

4. Internal Medicine, Albany Medical Center, Albany, New York, USA

5. Wadsworth Center, New York State Department of Health, Albany, New York, USA

6. School of Public Health, University at Albany, Albany, New York, USA

Abstract

In this work, a novel biosensor technology was used to measure antibody levels that resulted from vaccination against COVID-19 and/or from infection with the virus. Importantly, this approach enables quantification of antibody levels, which can provide information about the timing and level of immune response.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00890-21

Reference18 articles.

1. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study

2. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

3. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

4. Chang X Augusto GS Liu X Kündig TM Vogel M Mohsen MO Bachmann MF. 2021. BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced. bioRxiv. doi:10.1101/2021.03.13.435222:2021.03.13.435222.

5. Covid-19: What new variants are emerging and how are they being investigated?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rapid fluorescent plasmonic biosensor platform to diagnose Lyme disease from serum antibodies;Frontiers in Biological Detection: From Nanosensors to Systems XVI;2024-03-13

2. Dual detection of COVID-19 antigens and antibodies using nanoscale fluorescent plasmonic substrates;Experimental Biology and Medicine;2022-08-19

3. Prevalence of SARS-CoV-2 infection in Baja California, Mexico: Findings from a community-based survey in February 2021 in the Mexico-United States border;PLOS Global Public Health;2022-08-02